top of page

Values in Rs. in  Crores

Torrent Pharma Sep 23 Year on Year Revenue Zooms by 6.8% to Rs..2660 Crore and Year on Year Profit flies by 36.4% to Rs.386 Crore. Quarter to Quarter Revenue Zooms by 2.7% and Q to Q Profit grown by 2.1%

00:00 / 03:29
download (4).png

Revenue Analysis:

Torrent Pharma, has reported a revenue of Rs. 2660 Crore, which has crosses by 2.7% as compared to previous quarter revenue of Rs. 2591 Crore. As compared to revenue of September-22, there is a rise by 6.8% from Rs. 2491 Crore. to Rs. 2660 Crore.


Market Expectations V/s Actual

The Market Estimate of the Revenue was Rs.2633 Crore . Company's reported Revenue of Rs. 2660 is fairly in line with expectations.


Profit and Cost Analysis

Quarterly Profit has balloons by 36.4% to Rs.386 Crore from Rs. 283 Crore, when compared with year ago quarter results. In comparison with preceding quarter of June, 2023 , quarter profit has crosses by 2.1% to Rs.386 Crore from Rs. 378 Crore. Net Profit % of the Company has remained at 14.5% compared to 14.6% in previous quarter and 11.4% in year ago quarter.

On analysis, it is observed that this Quarter's EBITDA (Operating Profit) Margin has nearly maintains same to 31.0% from 30.5% as compared with June, 2023 quarter. The reason for the nearly stays similar of EBITDA Margin is due to,

a) Cost of Sales has nearly stays similar to 24.8% (Previous Quarter: 25.1%). Cost of Sales in absolute terms has rise from Rs. 650 Crore to 660 Crore.

b) Employee Cost has shrinks to 18.9% (Previous Quarter: 19.3%). Employee Cost in exact value has nearly maintains same from Rs. 499 Crore to 503 Crore.

c) Other Expenses has nearly maintains to 25.3% (Previous Quarter: 25.1%). Other Expenses zooms from Rs. 651 Crore to 672 Crore.


The finance cost has dwindle from Rs. 103 Crore to 91 Crore by -11.7%.


Key Matrix:

Price to Earning (PE) ratio of the company is 49.98 as compared to the Industry PE of 43.38. PE is better placed which signifies that neither company is overvalue or undervalued. Companies Return on Equity (ROE) is 19.9% and Return of Capital Employed (ROCE) is 21.2%.


Share Price Movement:

The Return on Share Prices were 1.6% in past one month, -5.8% in 3 months, 13.5% in 6 months, 18.9% in 12 months, 21.6% in 24 months.


Summary:

To summarize, as compared to June'23, Revenue has crosses by 2.7%. Gross Margin has nearly remains regular from 74.9% to 75.2%. EBITDA Margin has nearly maintains same to 31.0% from 30.5%. and Net Profit After Tax Margin has crosses to 14.5% from 14.6%.


The Brief of Quarterly Results is as follows:

Torrent Pharmaceuticals Ltd.

Particulars (In Cr.)
Sep, 2023
Jun, 2023
Mar, 2023
Dec, 2022
Revenue
2660
2591
2491
2491
Cost of Goods Sold
660
650
704
704
Employee Cost
503
499
441
441
Other Expenses
672
651
619
619
EBITDA
825
791
727
727
Depreciation
201
191
196
196
Interest Expense
91
103
107
107
Other Income
26
34
9
9
Profit B4 Excep. Items
559
531
433
433
Exception Items
0
0
0
0
Net Profit Before Tax
559
531
433
433
Taxes
173
153
146
146
Net Profit After Tax
386
378
287
287
Gross Margin %
75.20%
74.90%
71.70%
71.70%
Employee Cost %
18.90%
19.30%
17.70%
17.70%
Other Expense Cost %
25.30%
25.10%
24.80%
24.80%
EBITDA %
31.00%
30.50%
29.20%
29.20%
Net Profit After Tax %
14.50%
14.60%
11.50%
11.50%

Blue Dart Sep 23 Revenue as compared to Sep,22 Nearly Maintains by 0.1% to Rs.1324 Crore and Year on Year Profit turndowns by 22.0% to Rs.73 Crore. Quarter to Quarter Revenue Surge by 7.0% and Q to Q Profit increases sharply by 19.2%

00:00 / 03:44

Reliance Sep 23 Revenue as compared to Sep,22 Nearly Maintains by 0.9% to Rs.234956 Crore and Year on Year Profit flies by 28.2% to Rs.19878 Crore. Quarter to Quarter Revenue Surge by 11.4% and Q to Q Profit grown by 8.9%

00:00 / 03:57

JUBILANT PHARMOVA Sep 23 Revenue as compared to Sep,22 Zooms by 5.1% to Rs.1680 Crore and Year on Year Profit zooms by 1162.2% to Rs.62 Crore. Quarter to Quarter Revenue Zooms by 5.9% and Q to Q Profit spikes by 935.0%

00:00 / 04:24

Cipla Sep'23 Revenue as compared to Sep'22 Zooms by 14.6% to Rs.6678 Crore and Year on Year Profit zooms by 44.8% to Rs.1155 Crore. Quarter to Quarter Revenue Balloons by 16.4% and Q to Q Profit spikes by 121.4%

00:00 / 04:07

Maruti Suzuki Sep 23 Revenue as compared to Sep,22 Jumps by 23.8% to Rs.37073 Crore and Year on Year Profit flies by 78.2% to Rs.3764 Crore. Quarter to Quarter Revenue Surge by 14.6% and Q to Q Profit increases sharply by 49.1%

00:00 / 04:10
bottom of page